| dc.contributor.author | Nelson, D. | |
| dc.contributor.author | Spowart, J. | |
| dc.contributor.author | Crabb, H. | |
| dc.contributor.author | Dye, D. | |
| dc.contributor.author | Fox, S. | |
| dc.contributor.author | Metharom, P. | |
| dc.contributor.author | Proksch, S. | |
| dc.contributor.author | Jackaman, Connie | |
| dc.date.accessioned | 2017-04-04T02:46:55Z | |
| dc.date.available | 2017-04-04T02:46:55Z | |
| dc.date.created | 2017-04-03T10:56:19Z | |
| dc.date.issued | 2016 | |
| dc.identifier.citation | Nelson, D. and Spowart, J. and Crabb, H. and Dye, D. and Fox, S. and Metharom, P. and Proksch, S. et al. 2016. Despite generating a weak tumour-specific CTL response during tumour progression chemotherapy is only effective in elderly mice if T cells are present, International Congress of Immunology (ICI), pp. 873-873: WILEY-BLACKWELL. | |
| dc.identifier.uri | http://hdl.handle.net/20.500.11937/51857 | |
| dc.publisher | WILEY-BLACKWELL | |
| dc.title | Despite generating a weak tumour-specific CTL response during tumour progression chemotherapy is only effective in elderly mice if T cells are present | |
| dc.type | Conference Paper | |
| dcterms.source.volume | 46 | |
| dcterms.source.startPage | 873 | |
| dcterms.source.endPage | 873 | |
| dcterms.source.issn | 0014-2980 | |
| dcterms.source.title | EUROPEAN JOURNAL OF IMMUNOLOGY | |
| dcterms.source.series | EUROPEAN JOURNAL OF IMMUNOLOGY | |
| dcterms.source.conference | International Congress of Immunology (ICI) | |
| curtin.department | School of Biomedical Sciences | |
| curtin.accessStatus | Fulltext not available | |
